Semaglutide

( DrugBank: Semaglutide / KEGG DRUG: Semaglutide )

---

5 diseases

6. パーキンソン病

---

臨床試験数 : 2,817 / 薬物数 : 2,606 - (DrugBank : 348) / 標的遺伝子数 : 185 - 標的パスウェイ数 : 205 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

51. 全身性強皮症

---

臨床試験数 : 740 / 薬物数 : 813 - (DrugBank : 165) / 標的遺伝子数 : 140 - 標的パスウェイ数 : 231 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

84. サルコイドーシス

---

臨床試験数 : 196 / 薬物数 : 261 - (DrugBank : 78) / 標的遺伝子数 : 73 - 標的パスウェイ数 : 183 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

113. 筋ジストロフィー

---

臨床試験数 : 826 / 薬物数 : 680 - (DrugBank : 126) / 標的遺伝子数 : 86 - 標的パスウェイ数 : 188 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

299. 嚢胞性線維症

---

臨床試験数 : 1,885 / 薬物数 : 1,782 - (DrugBank : 252) / 標的遺伝子数 : 110 - 標的パスウェイ数 : 190 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries